Article

Sightpath expands social media efforts

Sightpath, a provider of mobile and fixed ophthalmic surgical products, ramped up social media efforts with Facebook, Twitter, Vimeo, LinkedIn, and a blog.

Bloomington, MN-Sightpath, a provider of mobile and fixed ophthalmic surgical products, has created a company blog, a Facebook page, a Twitter account, and a Vimeo channel, as well as a fortified LinkedIn profile.

The expanded social media efforts are designed to provide additional avenues for communication, networking with peers, and keeping abreast of industry advancements.

“We believe that our social media presence will provide the company with the means to develop deeper relationships and interaction with our customers, employees, and partners, and will give us the ability to respond to feedback virtually in real time,” said Jim Tiffany, president and chief executive officer for Sightpath Medical.

All of Sightpath’s social media efforts are supported by the company’s Web site, www.SightpathMedical.com, which was re-launched earlier this year. From that site, visitors can learn about the company’s customizable products, browse video content depicting mobilization in action, hear from customers, and log in to create customized marketing materials.

“The way in which people search for information and connect to those they do business with is evolving. Sightpath recognizes this trend,” said Nicole Monacell, director of marketing for Sightpath Medical. “We’re looking forward to communicating and interacting with our customers in a new way.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.